Waddell & Reed Financial’s Endologix Inc ELGX Stock Holding History
Bought
Maintained
Sold
Other funds holding ELGX
BCM
ACH
CWAM
CCM
TCM
RG
NMC
Waddell & Reed Financial's ELGX Position: Q1 2017 in Review
Waddell & Reed Financial sold out of Endologix Inc (ELGX) in Q1 2017, closing a stake of 44,450 shares — an estimated $2.54M sold.
Waddell & Reed Financial first reported a position in ELGX in Q2 2013 and held it in 15 quarters. The position peaked at $18.8M in Q4 2013. 129 funds tracked by Wall St. Rank hold ELGX as of Q1 2017.
- Waddell & Reed Financial reported no remaining Endologix Inc position as of Q1 2017 after selling out during the quarter.
- Waddell & Reed Financial sold 44,450 Endologix Inc shares in Q1 2017, an estimated $2.54M.
- Waddell & Reed Financial first reported a position in Endologix Inc in Q2 2013 and held it in 15 quarters.
- Waddell & Reed Financial's Endologix Inc position peaked at $18.8M in Q4 2013.
- 129 funds tracked by Wall St. Rank held Endologix Inc as of Q1 2017.
Based on Waddell & Reed Financial's 13F filing for Q1 2017, filed 15 May 2017.